PE
BLFS icon

Point72 Europe’s BioLife Solutions BLFS Stock Holding History

Point72 Europe’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$22.5K Buy
+882
New +$20.9K ﹤0.01% 459

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Point72 Europe's BLFS Position: Q3 2025 in Review

Point72 Europe opened a new position in BioLife Solutions (BLFS) in Q3 2025: 882 shares worth $22.5K. The stake represents ﹤0.01% of the portfolio and ranks #459 among its holdings.

192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • Point72 Europe held 882 shares of BioLife Solutions worth $22.5K as of Q3 2025.
  • BioLife Solutions was a new Point72 Europe position in Q3 2025.
  • BioLife Solutions made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #459 holding.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.